About Life Sciences Update
Our Life Sciences Updates are your chance to participate in high-energy, in-person events that bring together the industry and stakeholders from across the life sciences ecosystem to discuss the pressures and opportunities shaping the industry today.
You can expect concise, candid sessions that translate geopolitical turbulence, security and cyber resilience, evolving regulation and market access, and data-driven innovation into practical next steps for your organisation.
You will hear forward-looking perspectives on where policy and markets are heading, what to prioritise now, and how to convert compliance and risk management into value creation.
As always, engagement is central, with lively Q&A after each session and ample networking to compare experiences, test assumptions, and distil actions.
Next update: 26 March 2026
In an era of unprecedented global challenges, the Life Sciences sector faces complex legal and strategic questions that demand expert insight and collaborative solutions.
Our Life Sciences Update event brings together leading practitioners to explore critical developments shaping the industry – from the first 1,000 days of the Unified Patent Court to strategic licensing trends and multi-billion euro deal structures. We will examine cross-border IP litigation, trade secrets protection, and the practical experiences that define success in this dynamic field.
Whether you are navigating EU court litigation, structuring complex licensing agreements, or managing IP portfolios across jurisdictions, this event offers invaluable perspectives and networking opportunities with peers facing similar challenges.
We look forward to welcoming you to an engaging programme with presentations from both our in-house experts and key industry profiles from LEO Pharma and Zealand Pharma, followed by networking opportunities over lunch.
Program
8.30
Registry and breakfast
9.00-9.05
Welcome
Martin Dræbye Gantzhorn, Gorrissen Federspiel, Partner
9.05-9.15
The Life Sciences industry – navigating a time of unprecedented global turmoil
Martin Dræbye Gantzhorn, Gorrissen Federspiel, Partner
9.15-9.45
Complex cross-border EU IP litigation and litigation before the EU courts – mind the gaps
Henrik Saugmandsgaard Øe, Gorrissen Federspiel, Partner
9.45-10.15
The first 1,000 days of the unified patent court – have we gained greater insight into the advantages and disadvantages within the Life sciences industry?
Kenneth Kvistgaard-Aaholm, Gorrissen Federspiel, Partner
10.15-10.35
Networking
10.35-11.10
Strategic Licensing – Drafting pointers and trends
Søren Høgh Thomsen, Gorrissen Federspiel, Partner
11.10-11.30
Entering into and navigating multi-billion licensing deals
Fredrik Fredh, LEO Pharma, Head of Intellectual Property Rights
11.30-11.55
Litigating cross-border trade secrets and IP litigation – experiences
Martin Rahbek Kornum, Zealand Pharma, Head of Intellectual Property
11.55-12.00
Closing remarks
Martin Dræbye Gantzhorn, Gorrissen Federspiel, Partner
12.00-13.00
Networking and lunch
Time and place
Date: 26 March 2026
Time: 08:30 – 13:00.
Venue: Gorrissen Federspiel, Axel Towers, Axeltorv 2, 1609 Copenhagen
Course certificate:
A certificate can be issued in accordance with the rules on continuing mandatory training for lawyers and assistant attorneys upon participation in at least one more seminar.
Registration
You can register your attendance via the form below.